Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
Bickerstaff's Brainstem Encephalitis: Clinical Features of 62 Cases and a Subgroup Associated with Guillain-Barre Syndrome
Brain 126:2279-2290, Odaka,M.,et al, 2003
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003
Drug Treatments for Eye Movement Disorders
JNNP 74:1-4, Leigh,R.J., &Tomsak,R.L., 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Non-convulsive Status Epilepticus: Usefulness of Clinical Features in Selecting Patients for Urgent EEG
JNNP 74:189-191, Husain,A.M.,et al, 2003
Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003
Donepezil in Vascular Dementia
Neurol 61:479-486,429, Helme,R.,et al, 2003
Peripheral Third Cranial Nerve Enhancement in Multiple Sclerosis
AJNR 24:1390-1395, Bhatti,M.T.,et al, 2003
Early Alzheimer's Disease
NEJM 349:1056-1063, Kawas,C.H., 2003
Psychiatric Adverse Events During Levetiracetam Therapy
Neurol 61:704-706, Mula,M.,et al, 2003
Learning Disability
Lancet 362:811-821, Gillberg,C.&Soderstrom,H., 2003
Clinical Features and Neuropathology of Autosomal Dominant Spinocerebellar Ataxia (SCA17)
Ann Neurol 43:367-375, Rolfs,A.,et al, 2003
Vascular Syndromes of the Thalamus
Stroke 34:2264-2278, Schumahmann,J.D., 2003
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Gamma Hydroxybutyrate Intoxication
NEJM 349:1267-1275, Case 30-2003, 2003
Acute Effects and Recovery Time Following Concussion in Collegiate Football Players
JAMA 290:2556-2563,2604, McCrea,M.,et al, 2003
Discontinuation of Levetiracetam Because of Behavioral Side Effects
Neurol 61:1218-1221, White,J.R.,et al, 2003
End-of-Life Care and the Effects of Bereavement on Family Caregivers of Persons with Dementia
NEJM 349:1936-1942,1891, Schulz,R.,et al, 2003
Hypoglossal Neuropathy in Hereditary Neuropathy with Liability to Pressure Palsy
Neurol 61:1154-1155, Winter,W.C. &Juel,V.C., 2003
Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003
New-Onset Fecal Incontinence After Stroke
Stroke 34:144-150, Harari,D.,et al, 2003
Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003
CT Assessment of Conjugate Eye Deviation in Acute Stroke
Neurol 60:135-137, Simon,J.E.,et al, 2003
Neurologic Manifestations of Lightning Strikes
Neurol 60:182-185, Cherington,M., 2003
Acetylcholinesterase Inhibitors for Vascular Dementia and Alzheimer's Disease Combined With Cerebrovascular Disease
Stroke 34:584-586, Bowler,J.V., 2003
An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003
Detection of Pathologic Prion Protein in the Olfactory Epithelium in Sporadic Creutzfeldt-Jakob Disease
NEJM 348:711-719,681, Zanusso,G.,et al, 2003
Hashimoto Encephalopathy
Arch Neurol 60:164-171, Chong,J.Y.,et al, 2003
Low Blood Pressure and Risk of Dementia in the Kungsholmen Project
Arch Neurol 60:223-228, Qiu,C.,et al, 2003
Practice Parameter: Evaluation of the Child with Global Developmental Delay
Neurol 60:367-380, Shevell,M.,et al, 2003
Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003
Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003
CMT with Pyramidal Features
Neurol 60:696-699, Vucic,S.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Acute Ophthalmoplegia
Lancet 361:930, Brotman,d.J.,et al, 2003
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
NEJM 348:1215-1222, 1277, Vermeer,S.E.,et al, 2003
The 12 Year Prognosis of Unilateral Functional Weakness and Sensory Disturbance
JNNP 74:591-596,557, Stone,J.,et al, 2003
Why Should Neuroradiologist Study Patients with Smell Loss?
AJNR 24:556-557, Levy,L.M.&Henkin,R.I., 2003
Amnesia, Cerebral Atrophy, and Autoimmunity
Lancet 361:1266, Schott,J.M., et al, 2003
Intellectual Impairment in children with Blood Lead Concentrations Below 10 ug per Deciliter
NEJM 348:1517-1526,1515, Canfield,R.L.,et al, 2003
Identifying the Pattern of Olfactory Deficits in Parkinson Disease Using the Brief Smell Identification Test
Arch Neurol 60:545-549, Double,K.L.,et al, 2003
Emergency Calls in Acute Stroke
Stroke 34:1005-1009, Handschu,R.,et al, 2003
Alzheimer's Disease and Parkinson's Disease
NEJM 348:1356-1364, Nussbaum,R.L. &Ellis,C.E., 2003
Wrong-way Eyes with Thalamic Hemorrhage
Neurol 60:1524, Messe,S.R. &Cucchiara,B.L., 2003
Pain in the Neck
Lancet 361:1700, Nicholls,S.,et al, 2003
Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 289:2651-2662,2717, Shumaker,S.A.,et al, 2003